Join
Live feed
·
INSIDERFilingvia Quantisnow
Standard BioTools Inc. logo

President & CEO Egholm Michael sold $5,150 worth of shares (5,473 units at $0.94), decreasing direct ownership by 0.20% to 2,741,191 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LAB (Standard BioTools Inc.) and more on Quantisnow.